Morton Grove Pharmaceuticals recalls

Morton Grove Pharmaceuticals appears in 9 official U.S. recall notices indexed by RecallRadar, most recently on 2022-03-09.

Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.

• Dexamethasone Elixir, USP 0.5 mg/5 mL, Net: 8 fl oz (237 mL) bottle, Rx only, Manufactured By: Morton Grove Pharmaceuticals, Inc., Morton G…
  FDA Drug · Class II · 2022-03-09 · Morton Grove Pharmaceuticals
• Promethazine With Codeine Oral Solution, (Promethazine Hydrochloride 6.25 mg/5mL & Codeine Phosphate 10 mg/5 mL), 1 Pint (473 mL), Rx Only,…
  FDA Drug · Class II · 2021-09-29 · Morton Grove Pharmaceuticals
• Promethazine Syrup Plain, 6.25 mg/5 mL (Promethazine Hydrochloride Syrup, USP), 1 Pint (473 mL), Rx Only, Manufactured For: Wockhardt USA,…
  FDA Drug · Class II · 2021-09-29 · Morton Grove Pharmaceuticals
• Valproic Acid Oral Solution USP, (250 mg/5 mL), 1 Pint (473 mL), Rx Only, Manufactured For: Wockhardt USA, LLC, Parsippany, NJ 07054
  FDA Drug · Class II · 2021-09-29 · Morton Grove Pharmaceuticals
• Hydroxyzine Hydrochloride Oral Solution, USP (Syrup), 10 mg/5 mL, packaged in a) 4 fl oz (118 mL) bottle, NDC 60432-150-04, b) 1 pint (473…
  FDA Drug · Class II · 2020-12-30 · Morton Grove Pharmaceuticals
• Prednisolone Sodium Phosphate Oral Solution, 15 mg/5 mL, packaged in a 8 fl oz (237 mL) bottle, Rx only, Manufactured By Morton Grove Pharm…
  FDA Drug · Class II · 2019-10-16 · Morton Grove Pharmaceuticals
• Prednisolone Sodium Phosphate Oral Solution, 15 mg/5 mL, 8 fl oz (237 mL) Bottle, Rx only, Manufactured By: Morton Grove Pharmaceuticals, I…
  FDA Drug · Class II · 2018-08-15 · Morton Grove Pharmaceuticals
• Amoxicillin and Clavulanate Potassium for Oral Suspension, USP, 250/62.5 mg per 5 mL, 100 mL (when reconstituted) bottle, Rx Only, Manufact…
  FDA Drug · Class II · 2017-09-06 · Morton Grove Pharmaceuticals
• Lindane Lotion, USP 1%, For External use Only, Rx Only, 2 fl oz (60 mL) bottle, MGP, NDC 60432-833-60
  FDA Drug · Class III · 2016-01-27 · Morton Grove Pharmaceuticals